Advanced Pancreatic Cancer Successfully Treated with Biweekly Low-Dose Gemcitabine
スポンサーリンク
概要
- 論文の詳細を見る
A 74-year-old male was admitted to our hospital in August 2006 because of an exacerbation of the symptom of diabetes mellitus. Abdominal CT showed locally advanced cancer of the head of the pancreas with encasement of the superior mesenteric artery, suggesting that the lesion was unresectable. The patient was scheduled for treatment with gemcitabine at the standard dose of 1000 mg/m2 once a week for 3 consecutive weeks followed by a one week rest, but on day 7 of cycle 1, grade 3 of hematological toxicity was diagnosed, and the schedule was changed to biweekly administration at a dose of 1000 mg/m2. The biweekly low-dose gemcitabine regimen slightly reduced tumor size, and the regimen was continued for 12 months. This case suggests that this new biweekly regimen of gemcitabine can be used as a safe and effective first-line chemotherapy for patients with advanced pancreatic cancer who are unable to tolerate the standard regimen of gemcitabine.
著者
-
Hibi Toshifumi
Department Of Digestive Organ Medicine Keio University School Of Medicine
-
Nishida Jiro
Department Of Cell Biology And Anatomy College Of Medicine Po Box 245044 University Of Arizona
-
Kishikawa Hiroshi
Departments Of Internal Medicine And Gastroenterology Tokyo Dental College Ichikawa General Hospital
-
Morishita Tetsuo
Department Of Internal Medicine Tokyo Dental College
-
Inokuchi Sayaka
Department Of Internal Medicine Keio University School Of Medicine
-
Kaida Shogo
Department of Gastroenterology, Tokyo Dental College Ichikawa General Hospital
-
Kishikawa Hiroshi
Department of Gastroenterology, Tokyo Dental College Ichikawa General Hospital
-
Inokuchi Sayaka
Department of Gastroenterology, Tokyo Dental College Ichikawa General Hospital
関連論文
- DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8
- Primary hepatic presentation of Hodgkin's lymphoma : A case report
- A case of primary hepatic non-Hodgkin's lymphoma with chronic hepatitis C
- Induction therapy with twice-daily interferon-beta does not improve the therapeutic efficacy of consensus interferon monotherapy for chronic hepatitis C
- Clinical impact of a newly developed capsule endoscope : usefulness of a real-time image viewer for gastric transit abnormality
- Effect of ethanol on mouse hepatitis virus-induced cytotoxicity
- Hepatocellular Carcinoma in Keio Affiliated Hospitals : Diagnosis, Treatment, and Prognosis of this Disease
- Treatment of hepatitis C virus with peg-interferon and ribavirin combination therapy significantly affects lipid metabolism
- Inhibition of growth of human hepatoma cells by dual-function antisense IL-6 oligonucleotides
- Assessment of histological features and outocome of interferon therapy in chronic hepatitis C
- Kupffer cell-mediated cytotoxicity against hepatoma cells occurs through production of nitric oxide and adhesion via ICAM-1/CD18
- Oxidative stress in gastric mucosal injury: Role of platelet-activating factor-activated granulocytes
- Spatial heterogeneity of mucosal blood flow during ischemia-reperfusion injury of rat stomach investigated by laser Doppler perfusion imaging
- Antibody-dependent cell-mediated cytotoxicity against cell lines generated by liver-specific idiotype-bearing antibody
- Pouchitis atlas for objective endoscopic diagnosis
- EFFECT OF TEA CATECHINS ON GASTRIC SUBMUCOSAL CIRCULATION
- Reliability, validity, and responsiveness of the Japanese version of the Inflammatory Bowel Disease Questionnaire
- NOVEL TECHNIQUE OF ENDOSCOPIC SUBMUCOSAL DISSECTION USING AN EXTERNAL GRASPING FORCEPS FOR SUPERFICIAL GASTRIC NEOPLASIA
- New mechanism of transforming growth factor-β signaling in hepatoma : Dramatic up-regulation of tumor initiating cells and epidermal growth factor receptor expression
- Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis
- Cyclosporine for inflammatory bowel disease-an epoch-making therapy for corticosteroid-resistant or dependent patients?
- Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab
- Role of microRNAs on anti-cancer effect of a selective COX-2 inhibitor in human gastric cancer cells
- Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis
- Introduction and overview : recent advances in the immunotherapy of inflammatory bowel disease
- Regulation of Mouse Retinol Dehydrogenases and Retinal Dehydrogenases in Hepatocyte Differentiation
- Laparoscopically assisted ileocecal resection for Crohn's disease associated with intestinal stenosis and ileovesical fistula
- An Inverse Association between Serum Gamma Glutamyl Transpeptidase Activity and Breslow's Lifestyle Index; Its Practical Application for Screening of Subjects with Unhealthy Lifestyles
- Esophageal melanosis, an endoscopic finding associated with squamous cell neoplasms of the upper aerodigestive tract, and inactive aldehyde dehydrogenase-2 in alcoholic Japanese men
- Development of consensus statements for the diagnosis and management of intestinal Behcet's disease using a modified Delphi approach
- Association of the -173G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis
- Melanosis and squamous cell neoplasms of the upper aerodigestive tract in Japanese alcoholic men
- Sinusoidal endothelial fenestrae organization regulated by myosin light chain kinase and Rho-kinase in cultured rat sinusoidal endothelial cells
- Autoimmune pancreatitis with pseudocysts
- Overview : Helicobacter pylori and Extragastric Disease
- Psychological aspects of inflammatory bowel disease
- Association of pseudomembranous colitis with Henoch-Schonlein purpura
- Circulating autoantibodies against purified colonic mucin in ulcerative colitis
- Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis
- CLINICAL RESULTS OF ENDOSCOPIC HEMOSTASIS USING A SHORT TRANSPARENT HOOD AND SHORT HEMOCLIPS FOR NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING
- Lansoprazole promotes gastric mucosal mucosal cell proliferation and migration by activating p44/p42 mitogen-activated protein kinase
- Duodenal blood flow in acute portal hypertension
- Role of perforin and granzyme B of cytotoxic T lymphocyte in the onset of peptic ulcer formation
- Microvascular pathophysiology in gastric mucosal inflammation associated with H. pylori infection
- Changes of hepatic microcirculation in acute cholestasis
- HELICOBACTER PYLORI-ERADICATION THERAPY DECREASES THE LEVEL OF NEUTROPHIL-DERIVED OXIDANTS IN THE ULCEROUS MUCOSA OF THE HUMAN STOMACH : RELATIONSHIP BETWEEN ULCER STAGE AND MUCOSAL OXIDANT LEVEL
- Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease
- Autoimmune Hepatitis Associated with Pulmonary Arterial Hypertension
- Novel pathophysiological concepts of inflammatory bowel disease
- Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification
- Update on the pathophysiology of inflammatory bowel disease
- Coping strategy when patients with quiescent Crohn's disease recognize that their conditions are worsening
- Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis
- Animal models of inflammatory bowel disease
- Does Helicobacter pylori attack ghrelin-producing cells?
- Does an elemental diet affect operation and/or recurrence rate in Crohn's disease in Japan?
- Is fish oil (n-3 fatty acids) effective for the maintenance of remission in Crohn's disease?
- Immunoregulatory therapies targeting inflammatory cytokines against inflammatory bowel disease
- Enhanced ghrelin expression and subsequent acid secretion in mice with genetic H_2-receptor knockout
- Molecular Biological Studies of the Pathogenesis in Inflammatory Bowel Disease
- Tongue Metastasis as an Initial Presentation of a Lung Cancer
- Do immunosuppressants really work as maintenance therapy after the achievement of remission of severe ulcerative colitis?
- Biological therapies for inflammatory bowel disease
- Sugar microanalysis by HPLC with benzoylation : Improvement via introduction of a C-8 cartridge and a high efficiency ODS column
- Gastric mucosal response to Helicobacter pylori
- Genetics of inflammatory bowel disease in Japan
- Protective role of nitric oxide in the TNFα-mediated hepatic microvascular inflammatory response following acute ethanol ingestion
- Advanced Pancreatic Cancer Successfully Treated with Biweekly Low-Dose Gemcitabine
- Fulminant Hepatic Failure as the Initial Manifestation of Small-Cell Lung Cancer: Report of 2 Cases
- Diagnosis of toxic shock syndrome by two different systems : clinical criteria and monitoring of TSST-1-reactive T cells
- Intestinal macrophage, "a double-edged sword" for homeostasis and inflammation in the gut
- Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis : a Japanese nationwide randomized controlled trial
- Overexpression of apelin receptor (APJ/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver
- A Case of Intestinal Behçet's Disease Treated with Infliximab Monotherapy Who Successfully Maintained Clinical Remission and Complete Mucosal Healing for Six Years
- Microscopic Colitis with Granuloma Which Responded to Steroid Therapy
- Studies on the difference of lymphatic absorption between saturated and unsaturated long chain fatty acids in rats - Particularly in reference with the effect of puromycin and colchicine.:PARTICULARLY IN REFERENCE WITH THE EFFECT OF PUROMYCIN AND COLCHICI
- Interdisciplinary Collaboration
- Effects of Excessive Ethanol Consumption on the Diagnosis of the Metabolic Syndrome Using Its Clinical Diagnostic Criteria
- Non-alcoholic steatohepatitis-inducecl fibrosis : Toll-like receptors, reactive oxygen species and Jun N-terminal kinase
- Enhanced expressions of apelin on proliferative hepatic arterial capillaries in human cirrhotic liver